269 related articles for article (PubMed ID: 29103036)
1. The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
Tamagno E; Guglielmotto M; Monteleone D; Manassero G; Vasciaveo V; Tabaton M
J Alzheimers Dis; 2018; 62(3):1241-1245. PubMed ID: 29103036
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
Manassero G; Guglielmotto M; Zamfir R; Borghi R; Colombo L; Salmona M; Perry G; Odetti P; Arancio O; Tamagno E; Tabaton M
Aging Cell; 2016 Oct; 15(5):914-23. PubMed ID: 27406053
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
Shin WS; Di J; Cao Q; Li B; Seidler PM; Murray KA; Bitan G; Jiang L
Alzheimers Res Ther; 2019 Oct; 11(1):86. PubMed ID: 31627745
[TBL] [Abstract][Full Text] [Related]
4. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
6. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
7. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
9. Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D
FASEB J; 2020 Apr; 34(4):5092-5105. PubMed ID: 32067279
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
11. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease as oligomeropathy.
Ono K
Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
[TBL] [Abstract][Full Text] [Related]
13. The Role of Intracellular Ca
Jekabsone A; Jankeviciute S; Pampuscenko K; Borutaite V; Morkuniene R
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569690
[TBL] [Abstract][Full Text] [Related]
14. N-Terminal Hypothesis for Alzheimer's Disease.
Murray B; Sharma B; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
[TBL] [Abstract][Full Text] [Related]
15. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
[TBL] [Abstract][Full Text] [Related]
16. Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease.
Baram M; Atsmon-Raz Y; Ma B; Nussinov R; Miller Y
Phys Chem Chem Phys; 2016 Jan; 18(4):2330-8. PubMed ID: 26349542
[TBL] [Abstract][Full Text] [Related]
17. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
[TBL] [Abstract][Full Text] [Related]
18. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
[TBL] [Abstract][Full Text] [Related]
19. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
[TBL] [Abstract][Full Text] [Related]
20. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]